"Our care team at Ascension St. Mary's Hospital Seton Cancer Institute - Saginaw, Michigan, delivers personalized care for your needs. As part of our Ascension Michigan cancer services, our doctors and nurses listen to understand your questions and concerns and provide answers to your questions. Then we deliver a care plan with cancer-fighting treatments and support programs. Our medical, radiation and surgical oncologists and our cancer care team is dedicated to helping you defeat cancer."

During the past decade, Seton Cancer Institute at Saint Mary's - Saginaw conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 106 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 15 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seton Cancer Institute at Saint Mary's - Saginaw" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 71 trials, followed by "SWOG Cancer Research Network" with 40 trials sponsored, "Eastern Cooperative Oncology Group" with 16 trials sponsored, "Radiation Therapy Oncology Group" with 14 trials sponsored and "NSABP Foundation Inc" with 14 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seton Cancer Institute at Saint Mary's - Saginaw" #1 collaborator was "National Cancer Institute (NCI)" with 160 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Seton Cancer Institute at Saint Mary's - Saginaw" are "Breast Cancer" (40 trials), "Lung Cancer" (29 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Lymphoma" (12 trials) and "Prostate Cancer" (12 trials). Many other conditions were trialed in "Seton Cancer Institute at Saint Mary's - Saginaw" in a lesser frequency.

Most popular intervention types in "Seton Cancer Institute at Saint Mary's - Saginaw" are "Drug" (121 trials), "Other" (50 trials), "Biological" (43 trials), "Radiation" (33 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (29 trials), "carboplatin" (18 trials), "radiation therapy" (17 trials), "bevacizumab" (16 trials) and "cisplatin" (14 trials). Other intervention names were less common.

The vast majority of trials in "Seton Cancer Institute at Saint Mary's - Saginaw" are 122 trials for "All" genders, 30 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Seton Cancer Institute at Saint Mary's - Saginaw". undefined are not yet recruiting, undefined are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 138 completed trials in Seton Cancer Institute at Saint Mary's - Saginaw, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Seton Cancer Institute at Saint Mary's - Saginaw, 4 "Phase 1" clinical trials were conducted, 77 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".